Drugs / HAV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06576024 | Dec 2023 → Apr 2025 | HIV infectious disease, hepatitis A virus infection, immunodeficiency disease | LiuZhou People's Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HAV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06576024 ↗ |
| Modality | Vaccine | “HAV vaccine” NCT06576024 ↗ |